These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 27822611)

  • 1. Rivaroxaban for heparin-induced thrombocytopenia: adding to the evidence.
    Ong SY; Chin YA; Than H; Tan CW; Yap ES; Wong WH; Ng HJ
    Ann Hematol; 2017 Mar; 96(3):525-527. PubMed ID: 27822611
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of heparin-induced thrombocytopenia with rivaroxaban. Case report].
    Rivera O G; Corsi S O; Pavlovic J A; Aizman S A; Varas A P
    Rev Med Chil; 2017 Sep; 145(9):1213-1217. PubMed ID: 29424412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can rivaroxaban be a drug of choice for treating heparin-induced thrombocytopenia in a patient with pulmonary thromboembolism?
    Vavlukis M; Kotlar I; Taravari H; Poposka L; Kedev S
    Anatol J Cardiol; 2017 Jul; 18(1):77-79. PubMed ID: 28680014
    [No Abstract]   [Full Text] [Related]  

  • 4. Rivaroxaban in treatment refractory heparin-induced thrombocytopenia.
    Casan JM; Grigoriadis G; Chan N; Chunilal S
    BMJ Case Rep; 2016 Aug; 2016():. PubMed ID: 27520997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rivaroxaban for treatment of heparin-induced thrombocytopenia after cardiac surgery: A case report.
    Abouchakra L; Khabbaz Z; Abouassi S; Badaoui G
    J Thorac Cardiovasc Surg; 2015 Aug; 150(2):e19-20. PubMed ID: 26055438
    [No Abstract]   [Full Text] [Related]  

  • 6. Rivaroxaban as an Alternative Agent for Heparin-Induced Thrombocytopenia.
    Farasatinasab M; Zarei B; Moghtadaei M; Nasiripour S; Ansarinejad N; Zarei M
    J Clin Pharmacol; 2020 Oct; 60(10):1362-1366. PubMed ID: 32519800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed-onset heparin-induced thrombocytopenia without thrombosis in a patient receiving postoperative thromboprophylaxis with rivaroxaban.
    Tardy-Poncet B; Piot M; Montmartin A; Burdier A; Chalayer E; Tardy B
    Thromb Haemost; 2015 Aug; 114(3):652-4. PubMed ID: 26062524
    [No Abstract]   [Full Text] [Related]  

  • 8. Heparin-induced Thrombocytopenia Presenting With Deep Venous Thrombosis and Pulmonary Embolism Successfully Treated With Rivaroxaban: Clinical Case Report and Review of Current Experiences.
    Samoš M; Bolek T; Ivanková J; Stančiaková L; Kovář F; Galajda P; Kubisz P; Staško J; Mokáň M
    J Cardiovasc Pharmacol; 2016 Nov; 68(5):391-394. PubMed ID: 27464495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of the rivaroxaban for heparin-induced thrombocytopenia study.
    Linkins LA; Warkentin TE; Pai M; Shivakumar S; Manji RA; Wells PS; Crowther MA
    J Thromb Thrombolysis; 2014 Nov; 38(4):485-92. PubMed ID: 24549975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rivaroxaban and apixaban for the treatment of suspected or confirmed heparin-induced thrombocytopenia.
    Cirbus K; Simone P; Austin Szwak J
    J Clin Pharm Ther; 2022 Jan; 47(1):112-118. PubMed ID: 34704283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rivaroxaban for treatment of suspected or confirmed heparin-induced thrombocytopenia study.
    Linkins LA; Warkentin TE; Pai M; Shivakumar S; Manji RA; Wells PS; Wu C; Nazi I; Crowther MA
    J Thromb Haemost; 2016 Jun; 14(6):1206-10. PubMed ID: 27061271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First experiences with the use of rivaroxaban in the treatment of heparin-induced thrombocytopenia.
    Ng HJ; Than H; Teo EC
    Thromb Res; 2015 Jan; 135(1):205-7. PubMed ID: 24974053
    [No Abstract]   [Full Text] [Related]  

  • 13. Rivaroxaban for arterial thrombosis related to heparin-induced thrombocytopenia.
    Hantson P; Lambert C; Hermans C
    Blood Coagul Fibrinolysis; 2015 Mar; 26(2):205-6. PubMed ID: 25255239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choice of drugs for heparin-induced thrombocytopenia.
    Med Lett Drugs Ther; 2012 May; 54(1391):43-4. PubMed ID: 22643441
    [No Abstract]   [Full Text] [Related]  

  • 15. Rivaroxaban for treatment of HIT: a riveting first experience.
    Linkins LA; Warkentin TE
    Thromb Res; 2015 Jan; 135(1):1-2. PubMed ID: 25466840
    [No Abstract]   [Full Text] [Related]  

  • 16. [Apixaban as therapeutic option in nephropathy patients with heparin-induced thrombocytopenia (HIT)].
    Delgado-García G; Monreal-Robles R; Gallegos-Arguijo D; Marfil-Rivera J
    Gac Med Mex; 2015; 151(6):798-801. PubMed ID: 26581538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy of heparin-induced thrombocytopenia: therapeutic options and challenges in the clinical practices.
    Al-Eidan FA
    J Vasc Nurs; 2015 Mar; 33(1):10-20. PubMed ID: 25700733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rivaroxaban in the Treatment of Heparin-Induced Thrombocytopenia.
    Sartori M; Favaretto E; Cini M; Legnani C; Cosmi B
    J Thromb Thrombolysis; 2015 Oct; 40(3):392-4. PubMed ID: 25804370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Another off-label novel oral anticoagulant to HIT cardiac surgery patients.
    Bianchi CF; Petrucci O
    J Thorac Cardiovasc Surg; 2015 Aug; 150(2):e20-2. PubMed ID: 26048274
    [No Abstract]   [Full Text] [Related]  

  • 20. [Heparin-induced thrombocytopenia].
    Franchini M; Veneri D
    Recenti Prog Med; 2005 Sep; 96(9):433-5. PubMed ID: 16229325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.